Stock Evaluator: HeartFlow, Inc. (HTFL)

HeartFlow, Inc. HTFL

$25.23 -0.60 -2.32%
July 31, 2026 4:00:00 PM EST November 10, 2021 Volume: 685,317
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Technology

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient’s heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart’s arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies. Its platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. HeartFlow, Inc. was formerly known as Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009. The company was incorporated in 2007 and is headquartered in San Francisco, California.

Commentary & Analysis


Financial Summary

Share Statistics HTFL Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $2,175.9 $179.6 55%
Shares Out (Mil) 85.6 47.9 59%
Institutional Ownership 92.0% 78.6% 61%
Float (Mil) 66.3 40.1 54%
Beta na 1.22 na
Avg Daily Volume (000s) 1,081 205 72%
Price Change
(52-week)
na 41.0% na
Growth HTFL Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 13.7% na
Net Income (5yr) na (1.0%) na
EPS (5yr) na 15.5% na
Dividends (5yr) na 0.0% 0%
Cash Flow (5yr) na (15.5%) na
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 8 8 8
Current EPS ($0.134) ($0.486) ($0.274)
Month Ago EPS ($0.135) ($0.491) ($0.264)
# Rev Up 1 0 1
# Rev Down 2 1 1
Three Months Ago EPS ($0.135) ($0.516) ($0.300)
Year/Year Chg (58.1%) (84.7%) (101.6%)
Financials HTFL Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $191 $192 32%
Net Income (TTM) (Mil) ($112) ($9) 10%
EPS (TTM) ($1.971) ($0.500) 15%
Operating Cash Flow (TTM) (Mil) ($71) $8 7%
Net Cash Flow (TTM) (Mil) ($90) ($3) 15%
Long-Term Debt (Q1) (Mil) $20 $14 33%
Enterprise Value (Q1) (Mil) $2,310 $215 51%
Valuation HTFL Industry
Median
Percentile
(All Stocks)
P/B 7.60 1.22 86%
P/E na 36.1 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 2.0 na
Ratios HTFL Industry
Median
Percentile
(All Stocks)
Gross Margin 78.1% 61.6% 88%
Net Margin (58.4%) (29.3%) 11%
ROA (42.3%) (21.9%) 13%
ROE 37.1% (1.4%) 90%
Liabilities to Assets 16.9% 33.3% 11%
F-Score 3 4 19%

HeartFlow, Inc. did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors